Sharat Singh
Technik-/Wissenschafts-/F&E-Leiter bei PROSPECT RESOURCES LIMITED
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Eric d'Esparbes | M | 56 | 5 Jahre | |
| Jeffrey Alter | M | 61 | 5 Jahre | |
| Clarke Neumann | M | 60 | 10 Jahre | |
| Mark Wheatley | M | 62 | 3 Jahre | |
| Ian John Goldberg | M | - | 3 Jahre | |
| Jill Howe | F | 48 | 3 Jahre | |
| Adi Mohanty | M | 57 | 3 Jahre | |
| Lynne Powell | F | 57 | 5 Jahre | |
| Jeffrey Allen Ferrell | M | 49 | 10 Jahre | |
| Brian Kotzin | M | 74 | 5 Jahre | |
| Samuel Hosack | M | - | 6 Jahre | |
| Robyn Hatton | F | - | 11 Jahre | |
| Ariella Kelman | M | - | 1 Jahre | |
| John Maketo | M | - | 5 Jahre | |
| Michael Rhode | M | - | - | |
| Allison Luo | M | 50 | 7 Jahre | |
| Roger Tyler | M | - | 11 Jahre | |
| Guarav Gupta | M | - | 1 Jahre | |
| Harry Miller | M | - | 1 Jahre | |
| David Broomfield | M | - | 2 Jahre | |
| Zivanayi L. Rusike | M | 65 | 11 Jahre | |
| Gerry Fahey | M | 71 | 11 Jahre | |
| Paul W. Shabram | M | - | 2 Jahre | |
| James Winch | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Herb H. Hooper | M | 60 |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
| Alfred G. Merriweather | M | 70 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | 3 Jahre |
| Tom Baruch | M | 85 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
| Thomas G. Klopack | M | - |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
| John Mendlein | M | 64 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | 1 Jahre |
| André F. Marion | M | 88 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
| Stephen C. Macevicz | M | - |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
| Kevin Tang | M | 57 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
| Michael Dunn | M | 68 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 22 | 66,67% |
| Australien | 11 | 33,33% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sharat Singh
- Persönliches Netzwerk
